Berkeley, CA · Founded 2021 · Privately Held (backing)
Developer of optogenetic gene therapies designed for vision restoration purposes. Ray Therapeutics is based in Berkeley, CA and was founded in 2021. It has raised $106 million across 2 recorded rounds; the latest was a $14 million early-stage round in May 2023.
Last price · $/share
—
Implied valuation
—
Total raised
$106.0M
Last round
Early Stage VC
May 2023
Cap table — not yet on record
Ray Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ray Therapeutics with a free account
·Watch Ray Therapeutics: the Monday email on marks, rounds and moves
Where does Ray Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ray Therapeutics's 2 recorded funding rounds.
